LPC, DIVI to deliver healthy EBITDA growth: Amongst PL universe, we expect LPC and DIVI to report higher EBIDTA growth of 43.2% and 21.6% YoY, respectively. On the other hand, CIPLA, DRRD and ZYDUSLIF are projected to report YoY decline in EBITDA given the higher base in the US. SUNP is likely to deliver moderate revenue growth YoY led by the ramp-up in the specialty and domestic portfolios; however, higher opex will restrict EBIDTA growth....